TABLE 1.

Patient characteristics for laboratory-reported C. striatum compared to Staphylococcus spp. in clinical specimens^a

Characteristicb	Corynebacterium striatum (n = 256)		Coagulase-negative Staphylococcus (n = 1,537)		Staphylococcus aureus (n = 2,655)
	No.	%	No.	%	No.	%
Sex
Male	141	55.1	852	55.43	1,469	55.33
Female	115	44.9	685	44.57	1,186	44.67
Age (yr)
<20	3	1.2	18	1.17	39	1.47
20–29	15	5.9	123	8.00	345	12.99
30–39	19	7.4	148	9.63	272	10.24
40–49	26	10.2	188	12.23	355	13.37
50–59	65	25.4	326	21.21	533	20.08
60–69	72	28.1	379	24.66	578	21.77
70–79	36	14.1	237	15.42	353	13.30
80–89	16	6.3	97	6.31	160	6.03
>90	4	1.6	21	1.37	20	0.75
Source
Wound	67	26.2	180	11.71	449	16.91
Respiratory	61	23.8	3	0.20	455	17.14
Tissue (lymph node)	36	14.1	78	5.07	180	6.78
Bone	30	11.7	22	1.43	37	1.39
Blood	23	9.0	669	43.53	381	14.35
LVAD	7	2.7	5	0.33	7	0.26
Urine	3	1.2	296	19.26	141	5.31
Other, sterilec	14	5.5	211	13.73	348	13.11
Other, nonsteriled	15	5.9	73	4.75	657	24.75

^aAll isolates were isolated from clinical samples from 1 January 2013 to 31 December 2015.

^bLVAD, left ventricular assist device.

^cIncludes aspirate, biopsy, catheter tip, cerebrospinal fluid, hardware, joint fluid, pleural fluid, peritoneal fluid, shunt, stones, synovial fluid, and valve specimens.

^dIncludes cervical, cyst, cornea, drainage, genital, lesion, ocular swab, placenta, sinus, stool, ulcer, urethra, vaginal, vesicle, and wound specimens.